When what you see is not always what you get: raising the bar of evidence for new diagnostic imaging modalities

Authors
Sundahl, N.
Gillessen, Silke
Sweeney, C.
Ost, P.
Affiliation
Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium; Division of Radiotherapy and Imaging, Institute of Cancer Research, London, UK. Electronic address: nora.sundahl@ugent.be.
Issue Date
2020

Metadata
Show full item record
Abstract
Even though prostate-specific membrane antigen (PSMA)-positron emission tomography (PET)-computed tomography (CT) is more accurate than conventional imaging in prostate cancer patients, its impact on patient-relevant outcomes is unknown. We argue that more evidence is required before using PSMA-PET-CT as the standard of care for staging.
Citation
Sundahl N, Gillessen S, Sweeney C, Ost P. When What You See Is Not Always What You Get: Raising the Bar of Evidence for New Diagnostic Imaging Modalities. Eur Urol. 2020.
Journal
European Urology
URI
http://hdl.handle.net/10541/623348
DOI
10.1016/j.eururo.2020.07.029
PubMed ID
32847699
Additional Links
https://dx.doi.org/10.1016/j.eururo.2020.07.029
Type
Article
Language
en
Collections